Benzo (4, 5) thieno (2, 3-d) pyrimidin4-ones and their use in therapy

Details for Australian Patent Application No. 2004277311 (hide)

Owner Solvay Pharmaceuticals B.V.

Inventors Nyronen, Tommi; Johnson, Mark Stuart; Koskimies, Pasi; Johansson, Nina; Pentikainen, Olli Taneli; Salminen, Tiina Annamaria; Hirvela, Leena; Lehtovuori, Pakka

Agent Watermark

Pub. Number AU-B-2004277311

PCT Pub. Number WO2005/032527

Priority 60/477,047 10.06.03 US

Filing date 9 June 2004

Wipo publication date 14 April 2005

Acceptance publication date 29 April 2010

International Classifications

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2005/032527 Priority application(s): WO2005/032527

1 April 2010 Amendment Made

  The nature of the amendment is: Add the co-inventor Lehtovuori, Pakka

29 April 2010 Application Accepted

  Published as AU-B-2004277311

27 May 2010 Corrigenda

  Applications Accepted - Name Index Under the name Solvay Pharmaceuticals B.V., Application No. 2004277311, under INID (72) correct he co-inventor to read Lehtovuori, Pekka

26 August 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004277317-Assembly of an electrodynamic fractionating unit

2004277306-Container comprising code information elements